2018 Q3/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Cytogen
6.7
2 +5 Wockhardt
6.4
3 +7 Ligand Pharmaceuticals
6.2
4 +0 Zambon
6.1
5 +7 Galenica AG
6.1
6 +8 Astellas Europe
6.0
7 +2 Takeda
5.9
8 +97 Kyowa Hakko Kirin
5.9
9 +4 Meda Pharmaceuticals
5.8
10 +75 Santen
5.7
11 +16 Kyorin Holdings
5.7
12 +32 Pfizer UK
5.7
13 -10 Yakult UK
5.6
14 -9 Hetero
5.6
15 +1 Actelion
5.6
16 +7 BTG International
5.5
17 -9 Genus
5.5
18 +10 Julphar
5.5
19 +2 Takeda UK
5.4
20 +5 Zandu
5.3
21 +11 Abbott Uk
5.2
22 +12 Nippon Chemiphar
5.2
23 +36 ALK-Abello
5.2
24 -13 QLT
5.1
25 +90 Mitsubishi Tanabe
5.1
26 -6 Vitrolife
5.0
27 +15 Chugai - Pharma
5.0
28 -9 Debiopharm
5.0
29 +4 Bosnalijek
5.0
30 +46 Bavarian Nordic
5.0
31 +23 Laboratoires Thea UK
5.0
32 -8 Otsuka Pharmaceuticals Europe
5.0
33 -4 Baxter International
4.9
34 +100 Anavex Life Sciences Corp
4.9
35 +3 Apotex
4.8
36 +10 Acorda Therapeutics
4.7
37 -20 EISAI UK
4.7
38 +41 Dainippon Sumitomo
4.7
39 -8 Mitsubishi Tanabe Pharma Europe Ltd
4.7
40 -36 Nissan Chemical
4.7
41 -26 Lilly
4.7
42 -16 Toray Industries
4.7
43 +9 Intas Pharmaceuticals
4.7
44 +18 Impax Laboratories
4.7
45 +5 Wockhardt UK
4.6
46 +9 Bial Portela
4.6
47 +22 Sawai Pharmaceutical
4.6
48 +29 Stallergenes
4.6
49 +16 GlaxoSmithKline
4.6
50 +121 Medivir Group
4.6


Changes in rank are compared to 2018 Q2/Global Life Sciences. Since then, 3 sites entered the survey and 80 sites could not be included in the rankings (17 more since last time). Build your own. Report statistics.